Small risk of breast cancer seen with hormone contraceptives

December 7, 2017
Micrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumour beyond the lymph node. Credit: Nephron/Wikipedia

Modern birth control pills that are lower in estrogen have fewer side effects than past oral contraceptives. But a large Danish study suggests that, like older pills, they still modestly raise the risk of breast cancer, especially with long-term use.

Researchers found a similar risk with the progestin-only intrauterine device, and they couldn't rule out a risk for other hormonal contraceptives like the patch and the implant.

But the overall increased risk was small, amounting to one extra case of cancer among 7,700 women using such contraceptives per year. Experts who reviewed the research say women should balance the news against known benefits of the pill - including lowering the risk of other cancers.

"Hormonal contraception should still be perceived as a safe and effective option for family planning," said Dr. JoAnn Manson, chief of preventive medicine at Harvard's Brigham and Women's Hospital, who was not involved in the research.

Women in their 40s may want to consider non-hormonal IUDs, getting their tubes tied or talking with their partners about vasectomy, Manson said.

Studies of older have shown "a net cancer benefit" because of lowered risk of cancer of the colon, uterus and ovaries despite a raised , said Mia Gaudet, a breast cancer epidemiologist at the American Cancer Society.

There was optimism that newer, low-dose contraceptives would lower the breast cancer risk, but these results have dashed those hopes, said Gaudet, who wasn't involved in the research.

About 140 million women use some type of , including about 16 million in the United States.

Researchers analyzed health records of 1.8 million women, ages 15 to 49, in Denmark where a national health care system allows linking up large databases of prescription histories, cancer diagnoses and other information.

Results were published Wednesday in the New England Journal of Medicine. Novo Nordisk Foundation funded the research, but played no role in designing the study. The foundation has ties to the Danish pharmaceutical company Novo Nordisk, which primarily makes diabetes drugs and does not make contraceptives.

Current and recent use of hormonal contraceptives was associated with a 20 percent increased risk of breast cancer. Risk increased with longer use, from a 9 percent increase in risk with less than a year of use to a 38 percent increase after more than 10 years of use.

Digging further, the researchers found no differences among types of birth control pills. Because of fewer users, the results for the patch, vaginal ring, implant and progestin shot were less clear, but the analysis didn't rule out an increased breast cancer risk for those methods.

"No type of hormone contraceptive is risk-free unfortunately," said lead author Lina Morch of Copenhagen University Hospital.

Researchers accounted for education, childbirth and family history of breast cancer, but they weren't able to adjust for several other known such as alcohol use and limited physical activity, or protective factors such as breast-feeding.

Women with a family history of breast may want to ask their doctors about other contraceptives, said Dr. Roshni Rao, a breast surgeon at New York-Presbyterian/Columbia University Medical Center.

"Oral contraceptives are like any other medication," Rao said. "There are risks and there are benefits. If you have a reason to be taking them, it's perfectly reasonable to do so."

Explore further: Hormonal contraceptives and hair dyes increase breast cancer risk

Related Stories

Hormonal contraceptives and hair dyes increase breast cancer risk

March 9, 2017
In her recent doctoral dissertation, researcher Sanna Heikkinen from the University of Helsinki and Finnish Cancer Registry evaluates the contribution of the use of hormonal contraceptives and hair dyes to the spectrum of ...

Recent use of some birth control pills may increase breast cancer risk

August 1, 2014
Women who recently used birth control pills containing high-dose estrogen and a few other formulations had an increased risk for breast cancer, whereas women using some other formulations did not, according to data published ...

Type 2 diabetes associated with risk of aggressive breast cancer in black women

November 15, 2017
African American women with type 2 diabetes (often referred to as adult-onset diabetes) are at a greater risk for developing breast cancer.

Pregnancy poses no greater risk to breast cancer survivors

October 26, 2017
A recent study published in the Journal of the National Cancer Institute indicates that pregnancy does not incur a greater risk of relapse for survivors of breast cancer. The safety of pregnancy for women with history of ...

Study reveals contraceptive cancer risks

March 7, 2012
A study has revealed that injectable contraceptives that are widely used around the world influence the risk of developing several types of cancer.

Study raises doubts about safety of some forms of birth control pills

June 28, 2017
New research on how birth control pills affect the level of hormones in women's blood serum has found much higher levels of hormones in women who take birth control pills compared to women who don't.

Recommended for you

New therapeutic gel shows promise against cancerous tumors

February 21, 2018
Scientists at the UNC School of Medicine and NC State have created an injectable gel-like scaffold that can hold combination chemo-immunotherapeutic drugs and deliver them locally to tumors in a sequential manner. The results ...

Kinase inhibitor larotrectinib shows durable anti-tumor abilities

February 21, 2018
Three simultaneous safety and efficacy studies of the drug larotrectinib reported an overall response rate of 75 percent for patients ages four months to 76 years with 17 different cancer diagnoses. All patients had tumors ...

Five novel genetic changes linked to pancreatic cancer risk

February 21, 2018
In what is believed to be the largest pancreatic cancer genome-wide association study to date, researchers at the Johns Hopkins Kimmel Cancer Center and the National Cancer Institute, and collaborators from over 80 other ...

Similarities found in cancer initiation in kidney, liver, stomach, pancreas

February 21, 2018
Recent research at Washington University School of Medicine in St. Louis demonstrated that mature cells in the stomach sometimes revert back to behaving like rapidly dividing stem cells. Now, the researchers have found that ...

Research could change how doctors treat leukemia and other cancers fed by fat

February 21, 2018
Obesity and cancer risk have a mysterious relationship, with obesity increasing the risk for 13 types of cancer. For some cancers—including pediatric cancers—obesity affects survival rates, which are lower for people ...

New technique predicts gene resistance to cancer treatments

February 21, 2018
Yale School of Public Health researchers have developed a new method to predict likely resistance paths to cancer therapeutics, and a methodology to apply it to one of the most frequent cancer-causing genes.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.